Boston Medical Sciences
3 known investors
The company develops non-cathartic virtual colonoscopy technology to enable early detection of colorectal cancer, which ranks first in cancer incidence and second in cancer mortality in Japan. The solution aims to overcome patient resistance to traditional colonoscopy screening by offering a high-accuracy examination without laxative preparation.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AFeb 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Boston Medical Sciences do?
- The company develops non-cathartic virtual colonoscopy technology to enable early detection of colorectal cancer, which ranks first in cancer incidence and second in cancer mortality in Japan. The solution aims to overcome patient resistance to traditional colonoscopy screening by offering a high-accuracy examination without laxative preparation.
- Who are Boston Medical Sciences's investors?
- Boston Medical Sciences's investors include Beyond Next Ventures, Global Brain, JIC Venture Growth Investments.